Comparisons of togaviruses: Sindbis virus (group A) and Kunjin virus (group B).

R. W. Boulton,E. G. Westaway

DOI: https://doi.org/10.1016/S0042-6822(72)80029-1

IF: 3.513

1972-07-01

Virology

Abstract:

What problem does this paper attempt to address?

The senescence-associated secretome as an indicator of age and medical risk

Marissa J Schafer,Xu Zhang,Amanika Kumar,Elizabeth J Atkinson,Yi Zhu,Sarah Jachim,Daniel L Mazula,Ashley K Brown,Michelle Berning,Zaira Aversa,Brian Kotajarvi,Charles J Bruce,Kevin L Greason,Rakesh M Suri,Russell P Tracy,Steven R Cummings,Thomas A White,Nathan K LeBrasseur

DOI: https://doi.org/10.1172/jci.insight.133668

IF: 9.4958

2020-06-18

JCI Insight

Abstract:Produced by senescent cells, the senescence-associated secretory phenotype (SASP) is a potential driver of age-related dysfunction. We tested whether circulating concentrations of SASP proteins reflect age and medical risk in humans. We first screened senescent endothelial cells, fibroblasts, preadipocytes, epithelial cells, and myoblasts to identify candidates for human profiling. We then tested associations between circulating SASP proteins and clinical data from individuals throughout the life span and older adults undergoing surgery for prevalent but distinct age-related diseases. A community-based sample of people aged 20-90 years (retrospective cross-sectional) was studied to test associations between circulating SASP factors and chronological age. A subset of this cohort aged 60-90 years and separate cohorts of older adults undergoing surgery for severe aortic stenosis (prospective longitudinal) or ovarian cancer (prospective case-control) were studied to assess relationships between circulating concentrations of SASP proteins and biological age (determined by the accumulation of age-related health deficits) and/or postsurgical outcomes. We showed that SASP proteins were positively associated with age, frailty, and adverse postsurgery outcomes. A panel of 7 SASP factors composed of growth differentiation factor 15 (GDF15), TNF receptor superfamily member 6 (FAS), osteopontin (OPN), TNF receptor 1 (TNFR1), ACTIVIN A, chemokine (C-C motif) ligand 3 (CCL3), and IL-15 predicted adverse events markedly better than a single SASP protein or age. Our findings suggest that the circulating SASP may serve as a clinically useful candidate biomarker of age-related health and a powerful tool for interventional human studies.
Improvement of Cardiac Function after Coronary Artery Bypass Grafting Surgery Reduces the Risk of Postoperative Acute Kidney Injury

Jiarui Xu,Xin Chen,Yeqing Xie,Jing Lin,Wuhua Jiang,Jiawei Yu,Yimei Wang,Zhe Luo,Chunsheng Wang,Xiaoqiang Ding,Jie Teng,Bo Shen

DOI: https://doi.org/10.1002/clc.23785

2022-01-01

Clinical Cardiology

Abstract:Background Pre-existing renal dysfunction is an independent risk factor for cardiac surgery-associated acute kidney injury (AKI). We aimed to investigate whether the improvement of postoperative cardiac function after coronary artery bypass grafting (CABG) surgery would affect the risk of AKI in patients with different levels of baseline renal function. Methods Data were collected from patients who underwent CABG surgery from January 2018 to April 2019. Patients were divided into normal (GFR >= 90 ml/min/1.73 m(2)), non-CKD (60 <= GFR < 90 ml/min/1.73 m(2)), and CKD (GFR < 60 ml/min/1.73 m(2)) groups. Improvement in cardiac function was defined as oLVEF (postoperative LVEF-preoperative LVEF) >= 10% preoperative LVEF. Patients were further divided into subgroups according to postoperative cardiac function improvement. Results A total of 1365 patients were enrolled, including 793 (58.1%) in the normal group, 476 (34.9%) in the non-CKD group, and 96 (7.0%) in the CKD group. The AKI incidence in the normal, non-CKD, and CKD groups was 22.2%, 28.4%, and 40.6%, respectively. Patients with improved cardiac function in the non-CKD and CKD groups had significantly lower AKI incidence than those without improved cardiac function (22.8% vs. 36.9%, p = .002% and 32.8% vs. 54.3%, p = .037, respectively). For non-CKD patients with improved cardiac function, the serum creatinine at discharge was significantly lower than its preoperative serum creatinine (0.8 +/- 0.5 vs 1.2 +/- 0.9 mg/dl, p = .002). Multivariate logistic regression analysis showed that the improvement in cardiac function could reduce the risk for postoperative AKI in non-CKD patients but not in CKD patients. Conclusions For patients with renal dysfunction and mildly reduced eGFR (60 <= GFR < 90 ml/min/1.73 m(2)), improved cardiac function after CABG surgery can reduce the serum creatinine level and reduce the risk for postoperative AKI.
Novel Plasma Biomarker-Based Model for Predicting Acute Kidney Injury After Cardiac Surgery: A Case Control Study

Yichi Zhang,Haige Zhao,Qun Su,Cuili Wang,Hongjun Chen,Lingling Shen,Liang Ma,Tingting Zhu,Wenqing Chen,Hong Jiang,Jianghua Chen

DOI: https://doi.org/10.3389/fmed.2021.799516

IF: 3.9

2022-01-01

Frontiers in Medicine

Abstract:Introduction:Acute kidney injury (AKI) after cardiac surgery is independently associated with a prolonged hospital stay, increased cost of care, and increased post-operative mortality. Delayed elevation of serum creatinine (SCr) levels requires novel biomarkers to provide a prediction of AKI after cardiac surgery. Our objective was to find a novel blood biomarkers combination to construct a model for predicting AKI after cardiac surgery and risk stratification. Methods:This was a case-control study. Weighted Gene Co-expression Network Analysis (WGCNA) was applied to Gene Expression Omnibus (GEO) dataset GSE30718 to seek potential biomarkers associated with AKI. We measured biomarker levels in venous blood samples of 67 patients with AKI after cardiac surgery and 59 control patients in two cohorts. Clinical data were collected. We developed a multi-biomarker model for predicting cardiac-surgery-associated AKI and compared it with a traditional clinical-factor-based model. Results:From bioinformatics analysis and previous articles, we found 6 potential plasma biomarkers for the prediction of AKI. Among them, 3 biomarkers, such as growth differentiation factor 15 (GDF15), soluble suppression of tumorigenicity 2 (ST2, IL1RL1), and soluble urokinase plasminogen activator receptor (uPAR) were found to have prediction ability for AKI (area under the curve [AUC] > 0.6) in patients undergoing cardiac surgery. They were then incorporated into a multi-biomarker model for predicting AKI (C-statistic: 0.84, Brier 0.15) which outperformed the traditional clinical-factor-based model (C-statistic: 0.73, Brier 0.16). Conclusion:Our research validated a promising plasma multi-biomarker model for predicting AKI after cardiac surgery.
Pre-Operative Kidney Biomarkers and Risks for Death, Cardiovascular and Chronic Kidney Disease Events: The TRIBE-AKI Study

George Vasquez-Rios,Dennis G. Moledina,Yaqi Jia,Eric McArthur,Sherry G. Mansour,Heather Thiessen-Philbrook,Michael G. Shlipak,Jay L. Koyner,Amit X. Garg,Chirag R. Parikh,Steven G. Coca,TRIBE-AKI Consortium,

DOI: https://doi.org/10.1101/2021.12.13.21266784

2021-12-14

Abstract:ABSTRACT Background Soluble tumor necrosis factor receptor (sTNFR)1, sTNFR2, and plasma kidney injury molecule-1 (KIM-1) are associated with kidney events in patients with and without diabetes. However, their associations with clinical outcomes when obtained pre-operatively have not been explored. Methods The TRIBE-AKI cohort study is a prospective, multicenter, cohort study of high-risk adults undergoing cardiac surgery. We assessed the associations between pre-operative concentrations of plasma sTNFR1, sTNFR2, and KIM-1 and post-operative long-term outcomes including mortality, cardiovascular events, and chronic kidney disease (CKD) incidence or progression, ascertained after discharge. Results Among 1378 participants included in the analysis with a median follow-up period was 6.7 (IQR 4.0-7.9), 434 (31%) patients died, 256 (19%) experienced cardiovascular events and out of 837 with available long-term kidney function data, 30% developed CKD. After adjustment for clinical covariates, each log increase in biomarker concentration was independently associated with mortality with 95%CI adjusted hazard ratios (aHRs) of 3.0 (2.3-4.0), 2.3 (1.8-2.9) and 2.0 (CI 1.6-2.4) for sTNFR1, sTNFR2 and KIM-1, respectively. For cardiovascular events, the 95%CI aHRs were 2.1 (1.5 – 3.1), 1.9 (1.4 – 2.6) and 1.6 (1.2 – 2.1) for sTNFR1, sTNFR2 and KIM-1, respectively. For CKD events, the aHRs were 2.2 (1.5 – 3.1) for sTNFR1, 1.9 (1.3 – 2.7) for sTNFR2, and 1.7 (1.3 – 2.3) for KIM-1. Despite the associations, each of the biomarkers alone or in combination failed to result in robust discrimination on an absolute basis or compared to a clinical model. Conclusion sTNFR1, sTNFR2, and KIM-1 were independently associated with longitudinal outcomes after discharge from a cardiac surgery hospitalization including death, cardiovascular and CKD events when obtained pre-operatively in high-risk individuals. Pre-operative plasma biomarkers could serve to assist during the evaluation of patients in whom cardiac surgery is planned.
Biomarkers of Acute Kidney Injury after Cardiac Surgery: A Narrative Review

Binbin Wu,Jianghua Chen,Yi Yang

DOI: https://doi.org/10.1155/2019/7298635

2019-01-01

BioMed Research International

Abstract:Cardiac surgery-associated acute kidney injury (CSA-AKI) is a major and serious complication in patients undergoing cardiac surgery and is independently associated with perioperative mortality and mortality. Therapeutic intervention aiming at reversing kidney dysfunction seems disappointing across multiple settings. Consequently, attention has shifted from treatment to prevention and early detection. The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines have unified diagnostic standards mainly based on the serum creatinine (Scr) level or urine output, but neither marker is kidney specific. Efforts have been made to identify novel biomarkers with high sensitivity and specificity. The diagnostic capabilities of neutrophil gelatinase-associated lipocalin (NGAL) and G1 cell cycle arrest biomarker as biomarkers have been confirmed in a large number of clinical trials. The utility of biomarkers of cardiac function and inflammation has been validated in clinical studies. Aiming to offer valuable information for further research, we summarize the progress in defining current markers relevant to CSA-AKI in the last three years.
Senescence Biomarkers CKAP4 and PTX3 Stratify Severe Kidney Disease Patients

Sean McCallion,Thomas McLarnon,Eamonn Cooper,Andrew R. English,Steven Watterson,Melody El Chemaly,Cathy McGeough,Amanda Eakin,Tan Ahmed,Philip Gardiner,Adrian Pendleton,Gary Wright,Declan McGuigan,Maurice O’Kane,Aaron Peace,Ying Kuan,David S. Gibson,Paula L. McClean,Catriona Kelly,Victoria McGilligan,Elaine K. Murray,Frank McCarroll,Anthony J. Bjourson,Taranjit Singh Rai

DOI: https://doi.org/10.3390/cells13191613

IF: 6

2024-09-27

Cells

Abstract:Introduction: Cellular senescence is the irreversible growth arrest subsequent to oncogenic mutations, DNA damage, or metabolic insult. Senescence is associated with ageing and chronic age associated diseases such as cardiovascular disease and diabetes. The involvement of cellular senescence in acute kidney injury (AKI) and chronic kidney disease (CKD) is not fully understood. However, recent studies suggest that such patients have a higher-than-normal level of cellular senescence and accelerated ageing. Methods: This study aimed to discover key biomarkers of senescence in AKI and CKD patients compared to other chronic ageing diseases in controls using OLINK proteomics. Results: We show that senescence proteins CKAP4 (p-value < 0.0001) and PTX3 (p-value < 0.0001) are upregulated in AKI and CKD patients compared with controls with chronic diseases, suggesting the proteins may play a role in overall kidney disease development. Conclusions: CKAP4 was found to be differentially expressed in both AKI and CKD when compared to UHCs; hence, this biomarker could be a prognostic senescence biomarker of both AKI and CKD.

cell biology
Pre-operative kidney biomarkers and risks for death, cardiovascular and chronic kidney disease events after cardiac surgery: the TRIBE-AKI study

George Vasquez-Rios,Dennis G. Moledina,Yaqi Jia,Eric McArthur,Sherry G. Mansour,Heather Thiessen-Philbrook,Michael G. Shlipak,Jay L. Koyner,Amit X. Garg,Chirag R. Parikh,Steven G. Coca,for the TRIBE-AKI Consortium

DOI: https://doi.org/10.1186/s13019-022-02066-4

2022-12-26

Journal of Cardiothoracic Surgery

Abstract:Soluble tumor necrosis factor receptor (sTNFR)1, sTNFR2, and plasma kidney injury molecule-1 (KIM-1) are associated with kidney events in patients with and without diabetes. However, their associations with clinical outcomes when obtained pre-operatively have not been explored.

surgery,cardiac & cardiovascular systems
Risk factors for acute kidney injury and mortality in high risk patients undergoing cardiac surgery

Giuseppe Filiberto Serraino,Michele Provenzano,Federica Jiritano,Ashour Michael,Nicola Ielapi,Pasquale Mastroroberto,Michele Andreucci,Raffaele Serra

DOI: https://doi.org/10.1371/journal.pone.0252209

IF: 3.7

2021-05-21

PLoS ONE

Abstract:Background Acute Kidney Injury (AKI) represents a clinical condition with poor prognosis. The incidence of AKI in hospitalized patients was about 22–57%. Patients undergoing cardiac surgery (CS) are particularly exposed to AKI because of the related oxidative stress, inflammation and ischemia-reperfusion damage. Hence, the risk profile of patients undergoing CS who develop AKI and who are consequently at increased mortality risk deserves further investigation. Methods We designed a retrospective study examining consecutive patients undergoing any type of open-heart surgery from January to December 2018. Patients with a history of AKI were excluded. AKI was diagnosed according to KDIGO criteria. Univariate associations between clinical variables and AKI were tested using logistic regression analysis. Variable thresholds maximizing the association with AKI were measured with the Youden index. Multivariable logistic regression analysis was performed to assess predictors of AKI through backward selection. Mortality risk factors were assessed through the Cox proportional hazard model. Results We studied 158 patients (mean age 51.2±9.7 years) of which 74.7% were males. Types of procedures performed were: isolated coronary artery bypass (CABG, 50.6%), valve (28.5%), aortic (3.2%) and combined (17.7%) surgery. Overall, incidence of AKI was 34.2%. At multivariable analysis, young age ( p = 0.016), low blood glucose levels ( p = 0.028), estimated Glomerular Filtration Rate ( p = 0.007), pH ( p = 0.008), type of intervention ( p = 0.031), prolonged extracorporeal circulation (ECC, p = 0.028) and cross-clamp ( p = 0.021) times were associated with AKI. The threshold for detecting AKI were 91 and 51 minutes for ECC and cross-clamp times, respectively. At survival analysis, the presence of AKI, prolonged ECC and cross-clamp times, and low blood glucose levels forecasted mortality. Conclusions AKI is common among CS patients and associates with shortened life-expectancy. Several pre-operative and intra-operative predictors are associated with AKI and future mortality. Future studies, aiming at improving prognosis in high-risk patients, by a stricter control of these factors, are awaited.

multidisciplinary sciences
Clinical and Operative Determinants of Acute Kidney Injury after Cardiac Surgery

Faeq Husain-Syed,Maria Giovanna Quattrone,Fiorenza Ferrari,Pércia Bezerra,Salvador Lopez-Giacoman,Tommaso Hina Danesi,Sara Samoni,Massimo de Cal,Gökhan Yücel,Babak Yazdani,Werner Seeger,Hans-Dieter Walmrath,Horst-Walter Birk,Loris Salvador,Claudio Ronco

DOI: https://doi.org/10.1159/000507777

Abstract:Introduction: Cardiac surgery-associated acute kidney injury (CSA-AKI) is associated with increased morbidity and mortality. Objectives: We aimed to identify potentially modifiable risk factors for CSA-AKI. Methods: This was asingle-center retrospective cohort study of 495 adult patients undergoing cardiac surgery. AKI was diagnosed and staged using full KDIGO criteria incorporating baseline serum creatinine (SC) levels and correction of postoperative SC levels for fluid balance. We examined the association of routinely available clinical and laboratory data with AKI using multivariate logistic regression modeling. Results: A total of 103 (20.8%) patients developed AKI: 16 (15.5%) patients were diagnosed with AKI upon hospital admission, and 87 (84.5%) patients were diagnosed with CSA-AKI. Correction of SC levels for fluid balance increased the number of AKI cases to 104 (21.0%), with 6 patients categorized to different AKI stages. Univariate logistic regression analysis identified five preoperative (age, sex, diabetes mellitus, preoperative systolic pulmonary arterial pressure [PSPAP], acute decompensated heart failure) and five intraoperative predictors of AKI (age, sex, red blood cell [RBC] volume transfused, use of minimally invasive surgery, duration of cardiopulmonary bypass). When all preoperative and intraoperative variables were incorporated into one model, six predictors remained significant (age, sex, use of minimally invasive surgery, RBC volume transfused, PSPAP, duration of cardiopulmonary bypass). Model discrimination performance showed an area under the curve of 0.69 for the model including only preoperative variables, 0.76 for the model including only intraoperative variables, and 0.77 for the model including all preoperative and intraoperative variables. Conclusions: Use of minimally invasive surgery and therapies mitigating PSPAP and intraoperative blood loss may offer protection against CSA-AKI.
Development, validation, and comparative analysis of a simple clinical and laboratory-based risk score system for predicting and stratifying moderate-to-severe AKI after cardiac surgery

J T Zeng,X T Su,X H Huang,Z Zheng

DOI: https://doi.org/10.1093/eurheartj/ehad655.2743

IF: 39.3

2023-11-01

European Heart Journal

Abstract:Abstract Background Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) is prevalent and detrimental following cardiac surgery, without effective prevention. Early prediction and stratification are critical in informing appropriate care. Recent studies highlighted the predictive value of some routine laboratory markers in addition to traditional clinical variables. However, existing models suffer from complexity and practical difficulties in implementation. Purpose We aim to develop a high-performance preoperative risk score system for predicting moderate-to-severe CSA-AKI, while preserving its simplicity and utility through the integration of the most predictive and routinely accessible clinical and laboratory variables. Methods A total of 14 303 patients undergoing coronary artery bypass grafting surgery at a single institution, with comprehensive perioperative data, were included. Cohort 1 (N=9 416, 2013-2017) and cohort 2 (N=4 887, 2018-2019) were used to develop and validate a risk score system for predicting moderate-to-severe CSA-AKI, respectively, according to the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines. Bootstrapped stepwise regression was employed to select the robust candidate variables for a logistic regression model (i.e., the full model), which was then simplified to a more parsimonious model. Model performance was evaluated and compared to several established models. Results The overall incidence of moderate-to-severe CSA-AKI was 3.5% in the entire cohort. Two preoperative risk scores were developed: the simple 6-variable ABC2-Surgery2 score (age, a biomarker of NT-proBNP, two clinical status variables of hypertension and preoperative critical state, and two surgery-related variables of combined surgery and on-pump surgery), and the complete 10-variable AB2C3-Surgery4 score (ABC2-Surgery2 plus an additional biomarker of blood urea nitrogen, a clinical status variable of Canadian Cardiovascular Society angina class, and two surgery-related variables of urgent surgery and previous surgery). In the validation cohort, the simple score (area under the curve, AUC 0.765) outperformed the previously established UK-AKI model (AUC 0.720), Mehta score (AUC 0.700), and Ng score (AUC 0.697), while statistically similar to the most complex 19-variable Cleveland Clinic Score (AUC 0.725). The complete score (AUC 0.777) was superior to all four models. The current score system also effectively stratified CSA-AKI with respect to requirements for vasoactive support (measured by cumulative vasoactive-inotropic score), intravenous diuretics, and renal replacement therapy, as well as in-hospital and long-term mortality. Conclusion A simple risk score system incorporating routine clinical and laboratory variables was developed to predict and stratify moderate-to-severe CSA-AKI and outperformed previous complex models. Further external validation is currently underway for generalizability.

cardiac & cardiovascular systems
Urinary EGF and MCP-1 and risk of CKD after cardiac surgery

Steven Menez,Wenjun Ju,Rajasree Menon,Dennis G. Moledina,Heather Thiessen Philbrook,Eric McArthur,Yaqi Jia,Wassim Obeid,Sherry G. Mansour,Michael G. Shlipak,Steven G. Coca,Amit X. Garg,John A. Kellum,Matthias Kretzler,Chirag R. Parikh,Jay K. Koyner,Andrew S Bomback

DOI: https://doi.org/10.1172/jci.insight.147464

IF: 9.4958

2021-05-11

JCI Insight

Abstract:BACKGROUNDAssessment of chronic kidney disease (CKD) risk after acute kidney injury (AKI) is based on limited markers primarily reflecting glomerular function. We evaluated markers of cell integrity (EGF) and inflammation (monocyte chemoattractant protein-1, MCP-1) for predicting long-term kidney outcomes after cardiac surgery.METHODSWe measured EGF and MCP-1 in postoperative urine samples from 865 adults who underwent cardiac surgery at 2 sites in Canada and the United States and assessed EGF and MCP-1's associations with the composite outcome of CKD incidence or progression. We used single-cell RNA-Seq (scRNA-Seq) of AKI patient biopsies to perform transcriptomic analysis of programs corregulated with the associated genes.RESULTSOver a median (IQR) follow-up of 5.8 (4.2-7.1) years, 266 (30.8%) patients developed the composite CKD outcome. Postoperatively, higher levels of urinary EGF were protective and higher levels of MCP-1 were associated with the composite CKD outcome (adjusted HR 0.83, 95% CI 0.73-0.95 and 1.10, 95% CI 1.00-1.21, respectively). Intrarenal scRNA-Seq transcriptomes in patients with AKI-defined cell populations revealed concordant changes in EGF and MCP-1 levels and underlying molecular processes associated with loss of EGF expression and gain of CCL2 (encoding MCP-1) expression.CONCLUSIONUrinary EGF and MCP-1 were each independently associated with CKD after cardiac surgery. These markers may serve as noninvasive indicators of tubular damage, supported by tissue transcriptomes, and provide an opportunity for novel interventions in cardiac surgery.TRIAL REGISTRATIONClinicalTrials.gov NCT00774137.FUNDINGThe NIH funded the TRIBE-AKI Consortium and Kidney Precision Medicine Project. Yale O'Brien Kidney Center, American Heart Association, Patterson Trust Fund, Dr. Adam Linton Chair in Kidney Health Analytics, Canadian Institutes of Health Research, ICES, Ontario Ministry of Health and Long-Term Care, Academic Medical Organization of Southwestern Ontario, Schulich School of Medicine & Dentistry, Western University, Lawson Health Research Institute, Chan Zuckerberg Initiative Human Cell Atlas Kidney Seed Network.

medicine, research & experimental
The Association Between Novel Biomarkers and 1-Year Readmission or Mortality After Cardiac Surgery

Jeffrey P Jacobs,Shama S Alam,Sherry L Owens,Devin M Parker,Michael Rezaee,Donald S Likosky,David M Shahian,Marshall L Jacobs,Heather Thiessen-Philbrook,Moritz Wyler von Ballmoos,Kevin Lobdell,Todd MacKenzie,Allen D Everett,Chirag R Parikh,Jeremiah R Brown,Jeffrey P. Jacobs,Shama S. Alam,Sherry L. Owens,Devin M. Parker,Donald S. Likosky,David M. Shahian,Marshall L. Jacobs,Allen D. Everett,Chirag R. Parikh,Jeremiah R. Brown

DOI: https://doi.org/10.1016/j.athoracsur.2018.04.084

IF: 5.113

2018-10-01

The Annals of Thoracic Surgery

Abstract:BACKGROUND: Novel cardiac biomarkers including soluble suppression of tumorigenicity 2, galectin-3, and the N-terminal prohormone of brain natriuretic peptide may be associated with long-term adverse outcomes after cardiac surgery. We sought to measure the association between cardiac biomarker levels and 1-year hospital readmission or mortality.METHODS: Plasma biomarkers from 1,047 patients discharged alive after isolated coronary artery bypass graft surgery from 8 medical centers were measured in a cohort from the Northern New England Cardiovascular Disease Study Group between 2004 and 2007. We evaluated the association between preoperative and postoperative biomarkers and 1-year readmission or mortality using Kaplan-Meier estimates and Cox proportional hazards modeling, adjusting for covariates used in The Society of Thoracic Surgeons 30-day readmission model.RESULTS: The median follow-up time was 365 days. After adjustment for established risk factors, above-median levels of postoperative galectin-3 (median 10.35 ng/mL; hazard ratio, 1.40; 95% confidence interval, 1.08 to 1.80; p = 0.010) and N-terminal prohormone of brain natriuretic peptide (median = 15.21 ng/mL, hazard ratio, 1.42; 95% confidence interval, 1.07 to 1.87; p = 0.014) were each significantly associated with 1-year readmission or mortality.CONCLUSIONS: In patients undergoing cardiac surgery, novel cardiac biomarkers were associated with readmission or mortality independent of established risk factors. Measurement of these biomarkers may improve our ability to identify patients at highest risk for readmission or mortality before discharge. This will also allow resource allocation accordingly, while implementing strategies for personalized medicine based on the biomarker profile of the patient.
Risk Stratification for Postoperative Acute Kidney Injury in Major Noncardiac Surgery Using Preoperative and Intraoperative Data

Victor J. Lei,ThaiBinh Luong,Eric Shan,Xinwei Chen,Mark D. Neuman,Nwamaka D. Eneanya,Daniel E. Polsky,Kevin G. Volpp,Lee A. Fleisher,John H. Holmes,Amol S. Navathe

DOI: https://doi.org/10.1001/jamanetworkopen.2019.16921

2019-12-06

JAMA Network Open

Abstract:Importance: Acute kidney injury (AKI) is one of the most common complications after noncardiac surgery. Yet current postoperative AKI risk stratification models have substantial limitations, such as limited use of perioperative data.Objective: To examine whether adding preoperative and intraoperative data is associated with improved prediction of noncardiac postoperative AKI.Design, Setting, and Participants: A prognostic study using logistic regression with elastic net selection, gradient boosting machine (GBM), and random forest approaches was conducted at 4 tertiary academic hospitals in the United States. A total of 42 615 hospitalized adults with serum creatinine measurements who underwent major noncardiac surgery between January 1, 2014, and April 30, 2018, were included in the study. Serum creatinine measurements from 365 days before and 7 days after surgery were used in this study.Main Outcomes and Measures: Postoperative AKI (defined by the Kidney Disease Improving Global Outcomes within 7 days after surgery) was the primary outcome. The area under the receiver operating characteristic curve (AUC) was used to assess discrimination.Results: Among 42 615 patients who underwent noncardiac surgery, the mean (SD) age was 57.9 (15.7) years, 23 943 (56.2%) were women, 27 857 (65.4%) were white, and the most frequent surgery types were orthopedic (15 718 [36.9%]), general (8808 [20.7%]), and neurologic (6564 [15.4%]). The rate of postoperative AKI was 10.1% (n = 4318). The progressive addition of clinical data improved model performance across all modeling approaches, with GBM providing the highest discrimination by AUC. In GBM models, the AUC increased from 0.712 (95% CI, 0.694-0.731) using prehospitalization variables to 0.804 (95% CI, 0.788-0.819) using preoperative variables (inclusive of prehospitalization variables) (P < .001 for AUC comparison). The AUC further increased to 0.817 (95% CI, 0.802-0.832) when adding intraoperative variables (P < .001 for comparison vs model using preoperative variables). However, the statistically significant improvements in discrimination did not appear to be clinically significant. In particular, the AKI rate among patients classified as high risk improved from 29.1% to 30.0%, a net of 15 patients were appropriately reclassified as high risk, and an additional 15 patients were appropriately reclassified as low risk.Conclusions and Relevance: The findings of the study suggest that electronic health record data may be used to accurately stratify patients at risk of perioperative AKI, but the modest improvements from adding intraoperative data should be weighed against challenges in using intraoperative data.

medicine, general & internal
Cystatin C or creatinine for pre-operative assessment of kidney function and risk of post-operative acute kidney injury: a secondary analysis of the METS cohort study

John R Prowle,Bernard Croal,Thomas E F Abbott,Brian H Cuthbertson,Duminda N Wijeysundera,P S Myles,M A Shulman,S Wallace,C Farrington,B Thompson,M Ellis,B Borg,R K Kerridge,J Douglas,J Brannan,J Pretto,M G Godsall,N Beauchamp,S Allen,A Kennedy,E Wright,J Malherbe,H Ismail,B Riedel,A Melville,H Sivakumar,A Murmane,K Kenchington,Y Kirabiyik,U Gurunathan,C Stonell,K Brunello,K Steele,O Tronstad,P Masel,A Dent,E Smith,A Bodger,M Abolfathi,P Sivalingam,A Hall,T W Painter,S Macklin,A Elliott,A M Carrera,N C S Terblanche,S Pitt,J Samuels,C Wilde,K Leslie,A MacCormick,D Bramley,A M Southcott,J Grant,H Taylor,S Bates,M Towns,A Tippett,F Marshall,C D Mazer,J Kunasingam,A Yagnik,C Crescini,S Yagnik,C J L McCartney,S Choi,P Somascanthan,K Flores,D N Wijeysundera,W S Beattie,K Karkouti,H A Clarke,A Jerath,S A McCluskey,M Wasowicz,J T Granton,L Day,J Pazmino-Canizares,P Oh,R Belliard,L Lee,K Dobson,V Chan,R Brull,N Ami,M Stanbrook,K Hagen,D Campbell,T Short,J Van Der Westhuizen,K Higgie,H Lindsay,R Jang,C Wong,D Mcallister,M Ali,J Kumar,E Waymouth,C Kim,J Dimech,M Lorimer,J Tai,R Miller,R Sara,A Collingwood,S Olliff,S Gabriel,H Houston,P Dalley,S Hurford,A Hunt,L Andrews,L Navarra,A Jason-Smith,H Thompson,N McMillan,G Back,B L Croal,M Lum,D Martin,S James,H Filipe,M Pinto,S Kynaston,R M Pearse,T E F Abbott,M Phull,C Beilstein,P Bodger,K Everingham,Y Hu,E Niebrzegowska,C Corriea,T Creary,M Januszewska,T Ahmad,J Whalley,R Haslop,J McNeil,A Brown,N MacDonald,M Pakats,K Greaves,S Jhanji,R Raobaikady,E Black,M Rooms,H Lawrence,M Koutra,K Pirie,M Gertsman,S Jack,M Celinski,D Levett,M Edwards,K Salmon,C Bolger,L Loughney,L Seaward,H Collins,B Tyrell,N Tantony,K Golder,G L Ackland,R C M Stephens,L Gallego-Paredes,A Reyes,A Gutierrez del Arroyo,A Raj,R Lifford,

DOI: https://doi.org/10.1093/ckj/sfae004

2024-01-01

Clinical Kidney Journal

Abstract:ABSTRACT Background Post-operative acute kidney injury (PO-AKI) is a common surgical complication consistently associated with subsequent morbidity and mortality. Prior kidney dysfunction is a major risk factor for PO-AKI, however it is unclear whether serum creatinine, the conventional kidney function marker, is optimal in this population. Serum cystatin C is a kidney function marker less affected by body composition and might provide better prognostic information in surgical patients. Methods This was a pre-defined, secondary analysis of a multi-centre prospective cohort study of pre-operative functional capacity. Participants were aged ≥40 years, undergoing non-cardiac surgery. We assessed the association of pre-operative estimated glomerular filtration rate (eGFR) calculated using both serum creatinine and serum cystatin C with PO-AKI within 3 days after surgery, defined by KDIGO creatinine changes. The adjusted analysis accounted for established AKI risk factors. Results A total of 1347 participants were included (median age 65 years, interquartile range 56–71), of whom 775 (58%) were male. A total of 82/1347 (6%) patients developed PO-AKI. These patients were older, had higher prevalence of cardiovascular disease and related medication, were more likely to have intra-abdominal procedures, had more intraoperative transfusion, and were more likely to be dead at 1 year after surgery 6/82 (7.3%) vs 33/1265 (2.7%) (P = .038). Pre-operative eGFR was lower in AKI than non-AKI patients using both creatinine and cystatin C. When both measurements were considered in a single age- and sex-adjusted model, eGFR-Cysc was strongly associated with PO-AKI, with increasing risk of AKI as eGFR-Cysc decreased below 90, while eGFR-Cr was no longer significantly associated. Conclusions Data from over 1000 prospectively recruited surgical patients confirms pre-operative kidney function as major risk factor for PO-AKI. Of the kidney function markers available, compared with creatinine, cystatin C had greater strength of association with PO-AKI and merits further assessment in pre-operative assessment of surgical risk.

urology & nephrology
Plasma microRNA-21 for the early prediction of acute kidney injury in patients undergoing major cardiac surgery

Luise Gaede,Christoph Liebetrau,Johannes Blumenstein,Christian Troidl,Oliver Dörr,Won-Keun Kim,Karl Gottfried,Sandra Voss,Alexander Berkowitsch,Thomas Walther,Holger Nef,Christian W Hamm,Helge Möllmann

DOI: https://doi.org/10.1093/ndt/gfw007

Abstract:Background: Acute kidney injury (AKI) is a complication after major cardiac surgery that is associated with higher rates of morbidity and mortality. MicroRNA-21 (miR-21) has been described as an early biomarker for AKI. We investigated whether miR-21 is predictive of AKI and long-term mortality after cardiac surgery. Methods: Consecutive patients (n = 115) undergoing major cardiac surgery were included. Serum creatinine was measured prior to, 4 h after, and 1, 4 and 7 days after extracorporeal circulation. Diagnosis of post-operative AKI was made in accordance with the international Kidney Disease: Improving Global Outcomes definition of AKI. Serum cystatin C and miR-21 were measured prior to and 4 h after surgery. miR-21 was determined by quantitative RT-PCR and was normalized to miRNA-39 from Caenorhabditis elegans. The median follow-up time was 2.9 years. Results: AKI occurred in 36.5% (n = 42) of all patients. Baseline miR-21 was significantly lower in patients developing cardiac surgery-associated AKI (CSA-AKI) than in patients without CSA-AKI [0.27 (interquartile range, IQR, 0.14-0.30) versus 0.44 (IQR 0.25-0.75); P < 0.01]. Baseline miR-21 predicted CSA-AKI Stage 2/3 with an area under the curve of 0.701 [95% confidence interval (CI) 0.59-0.82; P = 0.007]. Baseline miR-21 <0.31 showed a hazard ratio of 3.11 (95% CI: 1.33-11.26) for CSA-AKI Stage 2/3. Patients with AKI Stage 2/3 had a significantly higher mortality (50 versus 10%; P = 0.0001) and dialysis rate (27 versus 11%; P = 0.038) within the 2.9-year follow-up. Conclusions: Our results indicate that miR-21 has the potential to identify patients at higher risk for CSA-AKI. This predictive value might be helpful in pre-procedural risk assessment and peri-procedural diagnosis and treatment.
Effect of reticuloendothelial blockers & stimulators on the evolution of experimental cholesterol atherosclerosis in pigs.

S. Pachauri,S. K. Mukherjee

Indian Journal of Experimental Biology

Abstract:
Biomarkers of eGFR decline after cardiac surgery in children: findings from the ASSESS-AKI study

Christina de Fontnouvelle,Michael Zappitelli,Heather R. Thiessen-Philbrook,Yaqi Jia,Paul L. Kimmel,James S. Kaufman,Prasad Devarajan,Chirag R. Parikh,Jason H. Greenberg

DOI: https://doi.org/10.1007/s00467-023-05886-1

2023-02-15

Pediatric Nephrology

Abstract:AbstractBackgroundChildren who require surgery for congenital heart disease have increased risk for long-term chronic kidney disease (CKD). Clinical factors as well as urine biomarkers of tubular health and injury may help improve the prognostication of estimated glomerular filtration rate (eGFR) decline.MethodsWe enrolled children from 1 month to 18 years old undergoing cardiac surgery in the ASSESS-AKI cohort. We used mixed-effect models to assess the association between urinary biomarkers (log2-transformed uromodulin, NGAL, KIM-1, IL-18, L-FABP) measured 3 months after cardiac surgery and cyanotic heart disease with the rate of eGFR decline at annual in-person visits over 4 years.ResultsOf the 117 children enrolled, 30 (24%) had cyanotic heart disease. During 48 months of follow-up, the median eGFR in the subgroup of children with cyanotic heart disease was lower at all study visits as compared with children with acyanotic heart disease (p = 0.01). In the overall cohort, lower levels of both urine uromodulin and IL-18 after discharge were associated with eGFR decline. After adjustment for age, RACHS-1 surgical complexity score, proteinuria, and eGFR at the 3-month study visit, lower concentrations of urine uromodulin and IL-18 were associated with a monthly decline in eGFR (uromodulin β = 0.04 (95% CI: 0.00–0.09; p = 0.07) IL-18 β = 0.07 (95% CI: 0.01–0.13; p = 0.04), ml/min/1.73 m2 per month).ConclusionsAt 3 months after cardiac surgery, children with lower urine uromodulin and IL-18 concentrations experienced a significantly faster decline in eGFR. Children with cyanotic heart disease had a lower median eGFR at all time points but did not experience faster eGFR decline.Graphical abstractA higher-resolution version of the Graphical abstract is available as Supplementary information.

pediatrics,urology & nephrology
Preoperative inflammatory biomarkers reveal renal involvement in postsurgical mortality in hip fracture patients: an exploratory study

Ana M. Valdes,Adeel Ikram,Lauren A. Taylor,Amy Zheng,Afroditi Kouraki,Anthony Kelly,Waheed Ashraf,Amrita Vijay,Suzanne Miller,Jessica Nightingale,Nicholas M. Selby,Benjamin J. Ollivere

DOI: https://doi.org/10.3389/fimmu.2024.1372079

IF: 7.3

2024-06-11

Frontiers in Immunology

Abstract:Background: Hip fractures in frail patients result in excess mortality not accounted for by age or comorbidities. The mechanisms behind the high risk of mortality remain undetermined but are hypothesized to be related to the inflammatory status of frail patients. Methods: In a prospective observational exploratory cohort study of hospitalized frail hip fracture patients, 92 inflammatory markers were tested in pre-operative serum samples and markers were tested against 6-month survival post-hip fracture surgery and incidence of acute kidney injury (AKI). After correcting for multiple testing, adjustments for comorbidities and demographics were performed on the statistically significant markers. Results: Of the 92 markers tested, circulating levels of fibroblast growth factor 23 (FGF-23) and interleukin-15 receptor alpha (IL15RA), both involved in renal disease, were significantly correlated with 6-month mortality (27.5% overall) after correcting for multiple testing. The incidence of postoperative AKI (25.4%) was strongly associated with 6-month mortality, odds ratio = 10.57; 95% CI [2.76–40.51], and with both markers plus estimated glomerular filtration rate (eGFR)– cystatin C (CYSC) but not eGFR-CRE. The effect of these markers on mortality was significantly mediated by their effect on postoperative AKI. Conclusion: High postoperative mortality in frail hip fracture patients is highly correlated with preoperative biomarkers of renal function in this pilot study. The effect of preoperative circulating levels of FGF-23, IL15RA, and eGFR-CYSC on 6-month mortality is in part mediated by their effect on postoperative AKI. Creatinine-derived preoperative renal function measures were very poorly correlated with postoperative outcomes in this group.

immunology
Biochemical Signals of Survival: A Study on Mortality Markers in Coronary Bypass Surgery Patients

Özlem Çakırköse,Ali Muhtaroğlu,Ersin Kuloglu

DOI: https://doi.org/10.7759/cureus.65456

2024-07-26

Cureus

Abstract:Background: Coronary bypass surgery remains a cornerstone treatment for advanced coronary artery disease. Identifying reliable predictors of postoperative mortality can significantly enhance patient care and outcomes. This study investigates the prognostic value of preoperative and postoperative amylase levels, creatinine, alanine aminotransferase, and aspartate aminotransferase as mortality markers in coronary bypass surgery patients. Methods: We conducted a retrospective analysis of 343 patients who underwent coronary bypass surgery. We compared the preoperative and postoperative biochemical markers (amylase, creatinine, alanine aminotransferase, and aspartate aminotransferase) of patients who died within the first week post-surgery (n = 52) and those who survived (n = 291). Statistical analyses included chi-square tests for categorical variables, t-tests for continuous variables, and receiver operating characteristic analysis for predicting mortality. Results: No significant difference was observed in the distribution of blood groups between deceased and surviving patients. However, significant differences were noted in gender distribution and mean ages, with higher mortality observed in older and male patients. Preoperative creatinine levels were significantly higher in patients who died compared to survivors. Postoperatively, deceased patients exhibited significantly higher levels of amylase, creatinine, alanine aminotransferase, and aspartate aminotransferase. Receiver operating characteristic analysis revealed that postoperative amylase, creatinine, alanine aminotransferase, and aspartate aminotransferase values were good predictors of mortality, with amylase being the most significant predictor. Conclusion: This study highlights the importance of biochemical markers, particularly amylase, as predictors of mortality in patients undergoing coronary bypass surgery. The findings suggest that monitoring and managing amylase, creatinine, alanine aminotransferase, and aspartate aminotransferase levels pre- and post-surgery could improve patient outcomes. This study lays the groundwork for further research into the mechanistic links between these biochemical markers and patient survival, potentially leading to improved prognostic tools and therapeutic strategies.
A new model to predict acute kidney injury requiring renal replacement therapy after cardiac surgery

Neesh Pannu,Michelle Graham,Scott Klarenbach,Steven Meyer,Teresa Kieser,Brenda Hemmelgarn,Feng Ye,Matthew James

DOI: https://doi.org/10.1503/cmaj.151447

2016-06-13

Canadian Medical Association Journal

Abstract:Background Acute kidney injury after cardiac surgery is associated with adverse in-hospital and long-term outcomes. Novel risk factors for acute kidney injury have been identified, but it is unknown whether their incorporation into risk models substantially improves prediction of postoperative acute kidney injury requiring renal replacement therapy. Methods We developed and validated a risk prediction model for acute kidney injury requiring renal replacement therapy within 14 days after cardiac surgery. We used demographic, and preoperative clinical and laboratory data from 2 independent cohorts of adults who underwent cardiac surgery (excluding transplantation) between Jan. 1, 2004, and Mar. 31, 2009. We developed the risk prediction model using multivariable logistic regression and compared it with existing models based on the C statistic, Hosmer–Lemeshow goodness-of-fit test and Net Reclassification Improvement index. Results We identified 8 independent predictors of acute kidney injury requiring renal replacement therapy in the derivation model (adjusted odds ratio, 95% confidence interval [CI]): congestive heart failure (3.03, 2.00–4.58), Canadian Cardiovascular Society angina class III or higher (1.66, 1.15–2.40), diabetes mellitus (1.61, 1.12–2.31), baseline estimated glomerular filtration rate (0.96, 0.95–0.97), increasing hemoglobin concentration (0.85, 0.77–0.93), proteinuria (1.65, 1.07–2.54), coronary artery bypass graft (CABG) plus valve surgery (v. CABG only, 1.25, 0.64–2.43), other cardiac procedure (v. CABG only, 3.11, 2.12–4.58) and emergent status for surgery booking (4.63, 2.61–8.21). The 8-variable risk prediction model had excellent performance characteristics in the validation cohort (C statistic 0.83, 95% CI 0.79–0.86). The net reclassification improvement with the prediction model was 13.9% (p < 0.001) compared with the best existing risk prediction model (Cleveland Clinic Score). Interpretation We have developed and validated a practical and accurate risk prediction model for acute kidney injury requiring renal replacement therapy after cardiac surgery based on routinely available preoperative clinical and laboratory data. The prediction model can be easily applied at the bedside and provides a simple and interpretable estimation of risk.

medicine, general & internal

Comparisons of togaviruses: Sindbis virus (group A) and Kunjin virus (group B).

The senescence-associated secretome as an indicator of age and medical risk

Improvement of Cardiac Function after Coronary Artery Bypass Grafting Surgery Reduces the Risk of Postoperative Acute Kidney Injury

Novel Plasma Biomarker-Based Model for Predicting Acute Kidney Injury After Cardiac Surgery: A Case Control Study

Pre-Operative Kidney Biomarkers and Risks for Death, Cardiovascular and Chronic Kidney Disease Events: The TRIBE-AKI Study

Biomarkers of Acute Kidney Injury after Cardiac Surgery: A Narrative Review

Senescence Biomarkers CKAP4 and PTX3 Stratify Severe Kidney Disease Patients

Pre-operative kidney biomarkers and risks for death, cardiovascular and chronic kidney disease events after cardiac surgery: the TRIBE-AKI study

Risk factors for acute kidney injury and mortality in high risk patients undergoing cardiac surgery

Clinical and Operative Determinants of Acute Kidney Injury after Cardiac Surgery

Development, validation, and comparative analysis of a simple clinical and laboratory-based risk score system for predicting and stratifying moderate-to-severe AKI after cardiac surgery

Urinary EGF and MCP-1 and risk of CKD after cardiac surgery

The Association Between Novel Biomarkers and 1-Year Readmission or Mortality After Cardiac Surgery

Risk Stratification for Postoperative Acute Kidney Injury in Major Noncardiac Surgery Using Preoperative and Intraoperative Data

Cystatin C or creatinine for pre-operative assessment of kidney function and risk of post-operative acute kidney injury: a secondary analysis of the METS cohort study

Plasma microRNA-21 for the early prediction of acute kidney injury in patients undergoing major cardiac surgery

Effect of reticuloendothelial blockers & stimulators on the evolution of experimental cholesterol atherosclerosis in pigs.

Biomarkers of eGFR decline after cardiac surgery in children: findings from the ASSESS-AKI study

Preoperative inflammatory biomarkers reveal renal involvement in postsurgical mortality in hip fracture patients: an exploratory study

Biochemical Signals of Survival: A Study on Mortality Markers in Coronary Bypass Surgery Patients

A new model to predict acute kidney injury requiring renal replacement therapy after cardiac surgery